Bridgepoint Group plc is a private equity and private credit firm focused on middle market, lower mid-market, small mid cap, small cap, growth capital, buyouts, syndicate debt, infrastructure, direct lending, and credit opportunities. It invests in sectors such as advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and Med-Tech outsourced services, pharma products, and Med-Tech products. The firm targets companies based in the United Kingdom, New York, Germany, Austria, Switzerland, Spain, France, and the Nordic region. It makes equity investments between £4.77 million ($5.91 million) and €300 million ($348.8 million), with specific ranges for small mid cap (£40 million to £125 million) and small cap (£10 million to £25 million), and targets enterprise values between €10 million ($10.74 million) and €1,000 million ($1,073.62 million). Founded in 1985, Bridgepoint Group plc is based in London, United Kingdom, with additional offices in North America, Asia, and Europe. It was formerly known as Bridgepoint Group Limited.